A list of active investigative brain tumor protocols in North America is presented. The fact that there are 138 protocols (and certainly some have been missed) indicates the diversity and intensity of research into this difficult problem. The geographic diversity of institutions involved in brain tumor clinical trials also underscores the opportunity available to a large number of clinicians caring for patients with brain tumors to refer them for participation in such a study.